4 October 2021 (Monday) - Morphology NEQAS

 The results of the latest NEQAS morphology became available today… only took a month for them to become available. Am I impatient in thinking this is far too long?

 2106 BF1 

 

My result

 

nrbc 

macrocytosis 

howell jolly bodies 

anisopoikilocytosis 

target cells 

rouleaux

Spherocytes

 

myelocytes 

neutrophilia

 

large platelets

 

Consensus

 

           

Nucleated RBCs

Spherocytes

Myelocyte

Monocytosis

Large/Giant Platelets

Blast Cells

Left Shift

Neutrophilia

Rouleaux

This turned out to be a case of haemolytic anaemia associated with malaria treatment with morphological changes of infection… I spotted all the salient features but yet again the diagnosis was rather silly in that if the chap was on treatment for malaria, we in the lab would have known it.

 

2106 BF2

My result

 

basophilic stippling

macrocytosis

nrbc

polychromsia

smear cells

target cells

 

cleft nuclei

 

platelet clumps

(?reduced nos)

 

Consensus

 

Nucleated RBCs

Polychromatic Cells

Howell-Jolly Bodies

Platelet Clumps

Thrombocytopaenia

Macrocytes

Lymphocytosis 7 124018

Agglutination

Myelocytes

Abnormal/Suspect Neoplastic Lymphocytes

 


This turned out to be a case of immune-mediated haemolysis and thrombocytopenia, with accompanying morphological changes in a chap with Evan’s syndrome with post splenectomy lymphocytosis…I’ll be honest, I saw read when I read the information given on the case; ” PSL  should  be  considered  in cases  of  a  mild  lymphocytosis  in  people  with  a  history  of splenectomy and no clinical features of lymphoma”… bearing in mind that when given the slides we were given no clinical information whatsoever.

 These NEQAS blood films (quite frankly) aren’t really much good these days. We are given blood films of patients well into the treatment of the most obscure conditions with absolutely no clinical information whatsoever. And are then lambasted for that not commenting which we would have got right had we been given all the information in the first place.

No comments:

Post a Comment